ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

Recruiting now · Not applicable

Conditions studied: Hepatitis C

In brief

The overall goals of the ETHOS II Project are to enhance hepatitis C virus (HCV) care in drug treatment clinics and needle and syringe programs (NSPs) in New South Wales and Australia, and to develop a translational framework for subsequent establishment of HCV screening and treatment programs in drug treatment clinics and NSPs across NSW and nationally.

Key facts

Study ID
NCT03685045
Run by
Kirby Institute
People needed
6000
Starts
2018-05-28
Expected to finish
2028-12-31
Last updated by the study team
2026-05-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.